Urotensin-II, oxidative stress, and inflammation increase in hypertensive and resistant hypertensive patients
- 11 November 2020
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 43 (3) , 211-216
Abstract
Objective: Hypertension is a multi-factorial process prevalent in developed as well as in developing countries. Urotensin-II, different antioxidants, free radicals, and inflammatory biomarkers play an essential role in the cardiovascular system. The aim of this study is to investigate Urotensin-II, oxidative stress, and inflammation markers in normotensive, hypertensive, and resistant hypertensive patients. Methods: Fifty resistance hypertensive (rHT) patients, 50 hypertensive patients, and 50 age gender matched normotensive controls (NT-control) were enrolled. Urotensin-II (UII), total oxidant status (TOS), total antioxidant status (TAS), native thiol (NT), total thiol (TT), disulfide (DIS), interleukin 1 beta (IL1β), interleukin 6 (IL6), tumor necrosis factor-alpha (TNFα), high sensitive c reactive protein (hsCRP), high-density lipoprotein (HDL) low-density lipoprotein (LDL), and total cholesterol (TC) were evaluated. Results: Serum levels of UII, IL1β, IL6, TNFα, DIS, TOS, and OSI were found higher in rHT and HT as compared to NT-control (p < .001). On the contrary, serum levels of TT, TAS, and NT were lower in rHT and HT as compared to NT-control (p < .001). While TC, hsCRP, TOS, OSI, UII, IL1β, IL6, and TNFα levels increase from HT to rHT group (p < .001); TAS and NT levels decrease from HT to rHT group (p < .001). Conclusions: UII levels, oxidative stress, and inflammation are higher in rHT and HT, while antioxidants and thiol levels are lower than the NT-control. Our study clearly showed that rHT and HT are more susceptible to impaired states of antioxidants, oxidative stress, and free radicals.Keywords
This publication has 42 references indexed in Scilit:
- Electronegative Low-Density Lipoprotein Increases C-Reactive Protein Expression in Vascular Endothelial Cells through the LOX-1 ReceptorPLOS ONE, 2013
- Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008Circulation, 2011
- Cysteine/cystine redox signaling in cardiovascular diseaseFree Radical Biology and Medicine, 2011
- Renal impairment, hypertension and plasma urotensin IINephrology Dialysis Transplantation, 2010
- Exercise urotensin II dynamics in myocardial infarction survivors with and without hypertensionInternational Journal of Cardiology, 2006
- C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferationCardiovascular Research, 2005
- Differential Effect of Urotensin II on Vascular Tone in Normal Subjects and Patients With Chronic Heart FailureCirculation, 2004
- Antioxidant Activities and Oxidative Stress Byproducts in Human HypertensionHypertension, 2003
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986